Agilent Technologies Receivables 2010-2024 | A

Agilent Technologies receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
  • Agilent Technologies receivables for the quarter ending July 31, 2024 were $1.227B, a 8.36% decline year-over-year.
  • Agilent Technologies receivables for 2023 were $1.291B, a 8.11% decline from 2022.
  • Agilent Technologies receivables for 2022 were $1.405B, a 19.88% increase from 2021.
  • Agilent Technologies receivables for 2021 were $1.172B, a 12.91% increase from 2020.
Agilent Technologies Annual Receivables
(Millions of US $)
2023 $1,291
2022 $1,405
2021 $1,172
2020 $1,038
2019 $930
2018 $776
2017 $724
2016 $631
2015 $606
2014 $626
2013 $899
2012 $923
2011 $860
2010 $869
2009 $595
Agilent Technologies Quarterly Receivables
(Millions of US $)
2024-07-31 $1,227
2024-04-30 $1,249
2024-01-31 $1,295
2023-10-31 $1,291
2023-07-31 $1,339
2023-04-30 $1,401
2023-01-31 $1,459
2022-10-31 $1,405
2022-07-31 $1,345
2022-04-30 $1,237
2022-01-31 $1,205
2021-10-31 $1,172
2021-07-31 $1,122
2021-04-30 $1,075
2021-01-31 $1,087
2020-10-31 $1,038
2020-07-31 $930
2020-04-30 $886
2020-01-31 $966
2019-10-31 $930
2019-07-31 $856
2019-04-30 $819
2019-01-31 $833
2018-10-31 $776
2018-07-31 $733
2018-04-30 $754
2018-01-31 $751
2017-10-31 $724
2017-07-31 $678
2017-04-30 $677
2017-01-31 $653
2016-10-31 $631
2016-07-31 $590
2016-04-30 $602
2016-01-31 $617
2015-10-31 $606
2015-07-31 $584
2015-04-30 $576
2015-01-31 $615
2014-10-31 $626
2014-07-31 $891
2014-04-30 $903
2014-01-31 $849
2013-10-31 $899
2013-07-31 $875
2013-04-30 $916
2013-01-31 $874
2012-10-31 $923
2012-07-31 $950
2012-04-30 $909
2012-01-31 $814
2011-10-31 $860
2011-07-31 $917
2011-04-30 $918
2011-01-31 $854
2010-10-31 $869
2010-07-31 $790
2010-04-30 $669
2010-01-31 $628
2009-10-31 $595
2009-07-31 $544
2009-04-30 $569
2009-01-31 $630
Sector Industry Market Cap Revenue
Computer and Technology Electrical Test Equipment $40.786B $6.833B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
AMETEK (AME) United States $39.882B 26.02
Fortive (FTV) United States $27.078B 21.53
Teradyne (TER) United States $21.836B 45.21
Cognex (CGNX) United States $6.831B 92.63
Itron (ITRI) United States $4.783B 22.83